Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 14-02-2022
The turnover is pegged at Rs. 5295.00 millions for the December 2021 quarter. The mentioned figure indicates a rise of about 60.02% as against Rs. 3309.00 millions during the year-ago period.An average growth of 30.90% was recorded for the quarter ended December 2021 to Rs. 716.00  millions from Rs. 547.00 millions.Operating Profit saw a handsome growth to 1193.00 millions from 1031.00 millions in the quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 5295.00 3309.00 60.02 12537.00 13420.00 -6.58 16535.00 17902.00 -7.64
Other Income 316.00 249.00 26.91 842.00 720.00 16.94 1011.00 1238.00 -18.34
PBIDT 1193.00 1031.00 15.71 3349.00 4132.00 -18.95 5187.00 7018.00 -26.09
Interest 41.00 30.00 36.67 91.00 90.00 1.11 113.00 206.00 -45.15
PBDT 1152.00 1001.00 15.08 3258.00 4042.00 -19.40 5074.00 6812.00 -25.51
Depreciation 355.00 294.00 20.75 1028.00 854.00 20.37 1152.00 981.00 17.43
PBT 797.00 707.00 12.73 2230.00 3188.00 -30.05 3922.00 5831.00 -32.74
TAX 81.00 160.00 -49.38 226.00 665.00 -66.02 827.00 1086.00 -23.85
Deferred Tax -61.00 90.00 -167.78 -171.00 -25.00 584.00 -106.00 -205.00 -48.29
PAT 716.00 547.00 30.90 2004.00 2523.00 -20.57 3095.00 4745.00 -34.77
Equity 365.00 364.00 0.27 365.00 364.00 0.27 365.00 364.00 0.27
PBIDTM(%) 22.53 31.16 -27.69 26.71 30.79 -13.24 31.37 39.20 -19.98